R.S. ZAMALEEVA, L.I. MALTSEVA, E.Yu. YUPATOV

Kazan State Medical Academy — Branch Campus of the RMACPE MOH Russia, 36 Butlerov Str., Kazan, Russian Federation, 420012

Zamaleeva R.S. ― D. Med. Sc., Professor of the Department of Obstetrics and Gynecology No.1, tel. +7-919-621-67-51, e-mail: zamaleewa@rambler.ru

Maltseva L.I. ― D. Med. Sc., Professor of the Department of Obstetrics and Gynecology No.1, tel. +7-905-314-40-51, e-mail: laramalc@mail.ru

Yupatov E.Yu. ― Cand. Med. Sc., Associate Professor of the Department of Obstetrics and Gynecology No.1, tel. +7-917-873-87-21, e-mail: evguenii@yahoo.com

The article presents a clinical case of maternal mortality from liver disease. The defects of prenatal care in the maternity welfare clinic and in-patient hospital are discussed. All stages of pregnancy and childbirth from the perspective of most recent data on the diseases of the liver during gestation are reviewed.

Key words: autoimmune hepatitis, high risk pregnancy, liver diseases in pregnant women, maternal mortality.

REFERENCES

1. Beznoshchenko G.B., Safonov A.D., Yarkov Ya.N. Zheltukhi u beremennykh [Jaundice in pregnant women]. Moscow: Meditsinskaya kniga, 2004. 76 p.
2. Shekhtman M.M. Rukovodstvo po ekstragenital’noy patologii u beremennykh [Manual on Extragenital Pathology in Pregnant Women]. Moscow: Triada-X, 2011. 892 p.
3. Eremina E.Yu. Autoimmune diseases of the liver and pregnancy. Prakticheskaya meditsina, 2011, no. 6, pp. 12–18 (in Russ.).
4. Klinicheskie rekomendatsii. Gastroenterologiya, pod red. V.T. Ivashkina [Clinical recommendations. Gastroenterology. Ed. by V.T. Ivashkin]. Moscow, 2006. 208 p.
5. Cooper G.S., Bynum M.L., Somers E.C. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmun., 2009, 33:197-207.
6. Wolf D.C., Raghuraman U.V. Autoimmune Hepatitis. New York Medical College, St John Medical Center. 2011. [Medline]
7. Michitaka K., Nishiguchi S., Aoyagi Y. et al. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol., 2009. 9; 30.
8. Longhi M.S., Ma Y., Mieli-Vergani G., Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun., 2009;17 (9): 186-9.
9. Alvarez F., Berg P.A., Bianchi F.B. et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol., 1999; 31 (5): 929-38.
10. Wiegard C., Schramm C., Lohse A.W. Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future. Semin Liver Dis. 2009; 29 (3): 254-61.
11. Manns M.P., Czaja A.J., Gorham J.D. et al. Diagnosis and management of autoimmune hepatitis. Hepatology, 2010; 51 (6): 2193-213.
12. Sherlok Sh., Duli Dzh. Zabolevaniya pecheni i zhelchnykh putey [Diseases of the liver and biliary tract]. Moscow, 1999.
13. Leyshner U. Autoimmunnye zabolevaniya pecheni i perekrestnyy sindrom [Autoimmune liver disease and cross syndrome]. Moscow, 2005. 176 p.
14. Candia L., Marquez J., Espinoza L.R. Autoimmune hepatitis and pregnancy: a rheumatologist’s dilemma. Semin Arthritis Rheum., 2005; 35 (1): 49-56.
15. Schramm C., Herkel J., Beuers U. et al. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol., 2006; 101 (3): 556-60.
16. Lineva O.I., Osadchenko E.Yu., Nesterenko S.A., Shmigol’ Yu.V., Gavripova T.A. Clinic and treatment of cholestatic hepatosis. Akusherstvo i ginekologiya, 2000, no. 2, pp. 15–17 (in Russ.).
17. Strassburg C.P., Manns M.P. Treatment of autoimmune hepatitis. Semin Liver Dis., 2009; 29 (3): 273-85.
18. Chan C.W., Gunsar F., Feudjo M. et al. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis. Aliment. pharmacol. ther., 2005. 2: 217-226.